Evidence map›Paper›PMID 30666522›Full record

ArticleAIDS and behavior2019

Debrief Reports to Expedite the Impact of Qualitative Research: Do They Accurately Capture Data from In-depth Interviews?

Jane M Simoni, Kristin Beima-Sofie, K Rivet Amico, Sybil G Hosek, Mallory O Johnson, Barbara S Mensch

2 registry-linked trialsAbstract read
In one paragraph

Article in AIDS and behavior, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02358616 completednot on this map

An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial

TypeobservationalSponsorMicrobicide Trials NetworkRan2012 to 2014Enrolled219ConditionsHIV Prevention
NCT07464236 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Partnering to Enhance Anal Health Communication and HIV-related Evidence-based Services

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2026 to 2030Enrolled8ConditionsHIV, Gonorrhea, Chlamydia, Anal Cancer Squamous CellArmsPEACHES 2.0 Implementation Strategies
3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jane M SimoniDepartment of Psychology, University of Washington, 3909 Stevens Way NE Campus Box 351525, Seattle, WA, 98195-1525, USA. jsimoni@uw.edu.ORCID http://orcid.org/0000-0002-8711-1576
Kristin Beima-SofieDepartment of Global Health, University of Washington, Seattle, WA, USA.
K Rivet AmicoDepartment of Health Behavior Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Sybil G HosekStroger Hospital of Cook County, Chicago, IL, USA.
Mallory O JohnsonUniversity of California, San Francisco, San Francisco, CA, USA.
Barbara S MenschPopulation Council, New York, NY, USA.

Funding

LOC: HIV Vaccine Trials NetworkUM1AI068614 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Dan H. Barouch, Lawrence Corey · 2011 to 2026
$1175.6M
Microbicide Trials NetworkUM1AI068633 · NIAID · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI HILLIER, SHARON L. · 2011 to 2021
$175.0M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Microbicide Trials NetworkU01AI068633 · NIAID · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI HILLIER, SHARON L. · 2006 to 2010
$77.0M
Statistical and Data Management Center (SDMC): Microbicide Trials NetworkUM1AI068615 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BROWN, ELIZABETH RENATA · 2011 to 2021
$66.5M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
Laboratory Center (LC): Microbicide Trials NetworkUM1AI106707 · NIAID · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI MELLORS, JOHN W, ROHAN, LISA CENCIA · 2014 to 2021
$27.1M
Mentoring and Empowerment in the Context of HIV Care for At-Risk PopulationsK24DA037034 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSON, MALLORY O · 2014 to 2018
$918k
Developing appropriate risk reduction interventions for pre-teensR21MH083308 · NIMH · WITS HEALTH CONSORTIUM (PTY), LTD · PI GRAY, GLENDA E, SIKKEMA, KATHLEEN J · 2008 to 2009
$331k
National Institute of Allergy and Infectious Diseases UM1AI068615National Institute of Allergy and Infectious Diseases UM1AI068633National Institute of Allergy and Infectious Diseases UM1AI106707NIAID NIH HHS P30 AI027757NIAID NIH HHS U01 AI068633NIAID NIH HHS UM1 AI068614NIAID NIH HHS UM1 AI068615NIAID NIH HHS UM1 AI068633NIAID NIH HHS UM1 AI106707NIDA NIH HHS K24 DA037034NIMH NIH HHS P30 MH062246NIMH NIH HHS R21 MH083308
6 · The paper itself

Abstract

"Debrief reports" (DRs) use structured forms to capture key concepts from in-depth interviews and focus group discussions. They are completed by interviewers and rapidly disseminated to key team members to facilitate identification of potential problems with study procedures, recruitment, or participant engagement and to inform critical adjustments, which can be especially pertinent in intervention studies. Their reliability and validity have yet to be formally evaluated. To assess the accuracy of DRs in capturing key content, raters analyzed a random sub-sample of 20 pairs of de-identified transcripts and their linked DRs from the VOICE-D trial. Analyses generally supported the accuracy of DRs; however, pertinent information from transcripts was occasionally missed or recorded with discrepancies or lack of detail. Longer transcripts and DR sections describing complex topic areas were more likely to involve discrepancies. Recommendations are offered for further research and optimizing the use of DRs.

Indexed as

Medication AdherenceQualitative ResearchAnti-HIV AgentsFocus GroupsHIV InfectionsHumansInterviews as TopicReproducibility of ResultsResearch PersonnelAnti-HIV AgentsAfricaDebrief reportsHIV/AIDSMedication adherenceQualitative data

Identifiers

PMID30666522
PMCPMC6642848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.